Mastocytosis Registry (of Zurich)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Zurich
About this trial
The study aims to summarize patients with mastocytosis and hypertryptasämia (without underlying mastocytosis or no bone marrow biopsy) in relation to demographic information, clinical progress and treatment courses. Biologic samples are collected from available routine diagnostics (serum, skin tissue, gut mucosa, bone marrow, and others) for further use in experimental research.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult patients with mastocytsis/hypertryptasemia which are treated at the university hospital of Zurich
available informed consent
Disqualifiers
denied consent
Trial population
all patients with mastocytosis or hypertryptasemia
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
400 Participants
are grouped into 2 trial groupsGroup A: Mastocytosis
Group B: Hypertryptasemia
Trial outcomes
Primary outcomes
1
Demographics
In the registry we collect patient's demographic data e.g. age, gender, comorbidities, smoking, preexisting atopic disease and other to look for associations to mast cell diseases.
Time frame
2010-20252
Disease progression
Patients will followed up over time to get more insight in disease progression.If there is progression detected (e.g. cutaneous mastocytosis to systemic mastocytosis or ISM to advanced forms) those cases will be carefully looked at to identify triggering factors and biomarkers.
Time frame
2010-2025Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov